IntroductionThe use of prokinetic agents on post-pyloric placement of spiral nasojejunal tubes is controversial. The aim of the present study was to examine if metoclopramide or domperidone can increase the success rate of post-pyloric placement of spiral nasojejunal tubes.MethodsA multicenter, open-label, randomized, controlled trial was conducted in seven hospitals in China between April 2012 and February 2014. Patients admitted to the intensive care unit and requiring enteral nutrition for more than three days were randomly assigned to the metoclopramide, domperidone or control groups (1:1:1 ratio). The primary outcome was defined as the success rate of post-pyloric placement of spiral nasojejunal tubes, assessed 24 hours after initial placement. Secondary outcomes included success rate of post-D1, post-D2, post-D3 and proximal jejunum placement and tube migration distance. Safety of the study drugs and the tubes during the entire study period were recorded.ResultsIn total, 307 patients were allocated to the metoclopramide (n = 103), domperidone (n = 100) or control group (n = 104). The success rate of post-pyloric placement after 24 hours in the metoclopramide, domperidone and control groups was 55.0%, 51.5% and 27.3%, respectively (P = 0.0001). Logistic regression analysis identified the use of prokinetic agents, Acute Physiology and Chronic Health Evaluation (APACHE) II score <20, Sequential Organ Failure Assessment (SOFA) score <12 and without vasopressor as independent factors influencing the success rate of post-pyloric placement. No serious drug-related adverse reaction was observed.ConclusionsProkinetic agents, such as metoclopramide or domperidone, are effective at improving the success rate of post-pyloric placement of spiral nasojejunal tubes in critically ill patients.Trial registrationChinese Clinical Trial Registry ChiCTR-TRC-12001956. Registered 21 February 2012.
Corrosion pits on pipelines lead to the formation of small holes, which cause further pipeline damage and even catastrophic consequences. Since many pipelines are located underground, the detection of corrosion pits on pipelines in real time is still an engineering challenge. In this paper, an experimental feasibility study on pipeline corrosion pit detection using the time reversal technique with a piezoceramic transducer as a time reversal mirror was investigated. A specimen of steel pipeline section was fabricated with an artificially drilled hole, which was to mimic a corrosion pit. By gradually increasing the depth of the hole, the evolution of the corrosion pit on the pipeline was simulated and studied. Two piezoceramic transducers were employed to generate a stress wave to propagate along the pipeline and to detect the propagated stress wave. With both the properties of sensing and actuating functions, a piezoceramic transducer was used as a time reversal mirror, which first detected the propagated stress wave signal and then sent 'back' the time-reversed signal as a propagating stress wave. With the inherent auto-focusing property of the time reversal technique, the detected time-reversed stress wave had a distinct focused peak. A corrosion pit on a pipeline, as a structural defect, reduces the energy of the focused signal received by the piezoceramic sensor and the attenuation ratio of the focused signal depends strongly on the degree of corrosion depth. Experimental results show that the amplitudes of the focused signal peak decrease with the increase of corrosion pit depth and we can use the peak amplitude of the focused signal to determine the state of pipeline corrosion. The time reversal based method proposed in this paper shows the potential to quantitatively monitor the damage degree of corrosion pits on pipelines in real time.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.